Neurological System Chronic Disease Flashcards
Peripheral Nervous System (PNS)
- sensory neurons run from stimulus receptors that inform CNS of stimuli
- motor neurons run from CNS to muscles and glands (effectors) that take action
Central Nervous System (CNS)
- consists of spinal cord and brain
- subdivided into sensory-somatic and automatic nervous systems
Sensory-Somatic Nervous System
12 pairs of cranial nerves
31 pairs of spinal nerves
-contain sensory and motor neurons
-all conscious awareness of external environment and motor activity to cope with it operate through sensory-somatic division
Autonomic Nervous System
- consists of sensory and motor neurons that run between CNS (especially hypothalamus and medulla oblongata) and various internal organs (ie heart, lungs, viscera, glands)
- contraction of smooth and cardiac muscle is controlled by motor neurons of the autonomic system
- 2 subdivisions: sympathetic and parasympathetic nervous systems
Sympathetic Nervous System
1) activates fight-or-flight response
2) sympathetic neurons frequently considered part of PNS, although many lie within CNS
3) sympathetic neurons of the spinal cord (which is part of the CNS) communicate with peripheral sympathetic neurons via series of sympathetic ganglia
Parasympathetic Nervous System
1) main nerves of PNS are 10th cranial and nerves
2) parasympathetic stimulation causes slowing of heartbeat
- lowering of BP
- constriction of pupils
- increased blood flow to skin and viscera
- peristalsis of GI tract
Parkinson’s Disease
goal of treatment:
1) medications to not halt progression of Parkinson’s disease (PD)
2) symptomatic relief from:
- dyskinesias
- resting tremors
- muscle rigidity
3) increased ability to perform ADLs by maintaining balance between dopamine and acetylcholine in extrapyramidal nervous system
Parkinson’s Disease: medications
1) dopaminergics:
- levodopa (Dopar, Larodopa)
- Levodopa plus carbidopa (Sinemet)
2) dopamine agonists:
- pramipexole (Mirapex)
3) centrally acting anticholinergics
- benztropine (Cogentin)
4) dopamine releaser (antiviral):
- amantadine (Symmetrel)
5) dopamine agonists:
- ropinirole (Requip)
- bromocriptine (Parlodel)
Common adverse effects of levodopa
1) nausea and vomiting
2) dyskinesias
3) orthostatic hypotension
4) discoloration of sweat and urine
5) activation of malignant melanoma
Treatment of Myasthenia Gravis
1) anticholinesterase agents
- help improve neuromuscular transmission
- increase muscle strength
- neostigmine and pyridostigmine
2) immunosuppressive medications:
- prednisone, azathioprine, cyclosporine, mycophenolate mofetil, and tacrolimus
- improve muscle strength by suppressing production of abnormal antibodies
- use must be carefully monitored by physician because they may cause major adverse effects
Medications to treat Seizures
1) phenobarbital
2) phenytoin
3) carbamazepine
4) ethosuximide
5) valproic acid
6) gabapentin
7) diazepam
phenytoin (Dilantin): nursing interventions and client education
1) advise clients about importance of oral hygiene
2) stop medication if client develops rash
3) encourage clients to consume enough vitamin D and calcium
valproic acid: nursing interventions and client education
1) clients at risk for hepatotoxicity, pancreatitis, and thrombocytopenia
2) take medication with food
3) advise clients to observe adverse effects and to notify provider if occur:
- anorexia
- nausea, vomiting
- abdominal pain
- jaundice
- bruising
Schizophrenia
- treatment goals
1) suppressing acute episodes
2) preventing acute recurrence
3) maintaining highest possible level of functioning - conventional antipsychotic medications control mainly positive symptoms:
- hallucinations
- delusions
- bizarre behavior of psychosis
- medications:
- chlorpromazine (Thorazine)
- haloperidol (Haldol)
haloperidol (Haldol) Adverse Effects
1) Acute dystonia
- treat with anticholinergic agents, such as benzatropine (Cogentin) or diphenhydramine (Benadryl)
- use oral doses for less acute effects and IM or IV doses for serious effects
2) parkinsonism
- treate with benzatropine, diphenhydramine, or amantadine (Symmetrel)
3) akathisia
- manage effects with beta-blocker, benzodiazepine, or anticholinergic medication
4) late extrapyramidal symptoms (EPSs), tardive dyskinesia (TD)
- evaluate client after 12 months of therapy, then every 3 months
- if indications of TD appear, lower dosage or switch client to an atypcial agent